Ancora Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Ancora Advisors, LLC

$4.08 Billion
Q4 2024

A detailed history of Ancora Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ancora Advisors, LLC holds 807 shares of VRTX stock, worth $370,413. This represents 0.01% of its overall portfolio holdings.

Number of Shares

807

Previous 807 -0.0%

Holding current value

$370,413

Previous $375,000 13.6%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $1,380 - $1,517	3 Added 0.37%	807 $375,000
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $30,639 - $37,871	-78 Reduced 8.84%	804 $376,000
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $54,222 - $59,328	133 Added 17.76%	882 $368,000
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $27,440 - $32,854	-80 Reduced 9.65%	749 $304,000
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $18,938 - $20,297	56 Added 7.24%	829 $288,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $4,716 - $5,278	15 Added 1.98%	773 $272,000
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $64,293 - $73,343	227 Added 42.75%	758 $238,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $25,432 - $28,611	89 Added 20.14%	531 $153,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $4,381 - $4,888	-16 Reduced 3.49%	442 $128,000
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $19,501 - $24,281	83 Added 22.13%	458 $129,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $58,676 - $69,157	265 Added 240.91%	375 $98,000
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $30,998 - $36,535	-140 Reduced 56.0%	110 $24,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $11,682 - $14,747	66 Added 35.87%	250 $55,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $13,422 - $15,021	74 Added 67.27%	184 $33,000
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $15,318 - $20,430	74 Added 205.56%	110 $26,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $7,669 - $9,093	30 Added 500.0%	36 $10,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $1,000 - $1,343	6 New	6 $1,000

Others Institutions Holding VRTX

# of Institutions

1,745

Shares Held

227M

Call Options Held

1.53M

Put Options Held

1.4M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $118B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Vertex Pharmaceuticals Inc Transaction History